CD4 and neoplasm: Beyond the extensively studied CD8+ T cell compartment, CD4+ T cells, non‐T immune cells, and tumor cells also show numerical and/or functional changes after PD‐1/PD‐L1 blockade, implying their roles as potential responders of PD‐1/PD‐L1 blockade.